Sector consensus Vanda Pharmaceuticals Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 10/04/2026 BST			5-day change	1st Jan Change
7.220 ^USD	-1.50%		+3.14%	-18.14%

04-09	Vanda Asks FDA to Withdraw Proposal Extending Drug Review Timelines	MT
04-08	Vanda Pharmaceuticals Starts Study of Nereus to Address GLP-1 Side Effects	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
VANDA PHARMACEUTICALS INC.			15.5	+111.46%	5
ARGENX SE			841.21	+24.33%	15
WUXI APPTEC CO., LTD.			134.62	+26.77%	18
INSMED INCORPORATED			212.79	+33.34%	19
BIONTECH SE			112.79	+41.89%	18
WUXI BIOLOGICS (CAYMAN) INC.			39.6	+27.76%	21
GENMAB A/S			2,232.52	+23.86%	14
AKESO, INC.			150.94	+27.78%	21
SUMMIT THERAPEUTICS INC.			22.9	+57.13%	14
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.			533.22	+9.9%	17
MADRIGAL PHARMACEUTICALS, INC.			668.57	+27.52%	14
EXELIXIS, INC.			46.83	+3.13%	18
ARROWHEAD PHARMACEUTICALS, INC.			81.09	+22.44%	11
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	770,000	+48.94%	1
VAXCYTE, INC.			109	+76.69%	9
NUVALENT, INC.			142.39	+36.14%	18
CYTOKINETICS, INCORPORATED			92.82	+43.71%	17
PHARMAESSENTIA CORPORATION			757	+19.97%	7
IMMUNITYBIO, INC.			14.8	+97.86%	5
BELITE BIO, INC			211.5	+16.74%	8
Average			38,821.01	+38.87%	14
Weighted average by Cap.			21,034.33	+31.87%	16